PFGIA
PDLI

Patriot Financial Group Insurance Agency’s PDL BioPharma, Inc. PDLI Stock Holding History

Patriot Financial Group Insurance Agency’s Portfolio PDLI Stock Details PDLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-100
Closed – – 1484
2019
Q1 		$0 Hold
100
– – ﹤0.01% 1362
2018
Q4 		$0 Hold
100
– – ﹤0.01% 1189
2018
Q3 		$1K Buy
+100
New +$245 ﹤0.01% 990

Other funds holding PDLI

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Patriot Financial Group Insurance Agency's PDLI Position: Q2 2019 in Review

Patriot Financial Group Insurance Agency sold out of PDL BioPharma, Inc. (PDLI) in Q2 2019, closing a stake of 100 shares.

Patriot Financial Group Insurance Agency first reported a position in PDLI in Q3 2018 and held it in 3 quarters. The position peaked at $1K in Q3 2018. 148 funds tracked by Wall St. Rank hold PDLI as of Q2 2019.

  • Patriot Financial Group Insurance Agency reported no remaining PDL BioPharma, Inc. position as of Q2 2019 after selling out during the quarter.
  • Patriot Financial Group Insurance Agency sold 100 PDL BioPharma, Inc. shares in Q2 2019.
  • Patriot Financial Group Insurance Agency first reported a position in PDL BioPharma, Inc. in Q3 2018 and held it in 3 quarters.
  • Patriot Financial Group Insurance Agency's PDL BioPharma, Inc. position peaked at $1K in Q3 2018.
  • 148 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q2 2019.

Based on Patriot Financial Group Insurance Agency's 13F filing for Q2 2019, filed 7 Aug 2019.